Operational view
SCIP, article, and compliance checks
Decabromodiphenyl ether is currently surfaced as pops regulation substance in the EU.
This page turns the imported framework rows into task prompts. It is meant to answer the operational question after the status question, especially when teams need SCIP, article, procurement, or substitution guidance.
How to use this obligations page
The obligations route should frame DecaBDE as a legacy-portfolio review problem: imported goods, older electronics, plastics, and the need for restriction-aware follow-up rather than a purely present-or-not-present checklist.
Check Candidate List threshold and SCIP relevance
Use this when the substance may sit in articles, components, or imported goods and you need to confirm communication and SCIP workflows.
Restriction reviewReview concentration limits, exemptions, and phase-out logic
POPs-facing compounds usually need a tighter review of restriction scope and any remaining exemption logic before continued use is assumed.
Portfolio reviewScreen affected product families and formulations
The use profile suggests this substance can appear in materials portfolios where one listing can ripple across multiple SKUs, suppliers, or component bills.
AlternativesOpen structurally nearby substances before substitution work starts
The alternatives route groups lower-pressure neighbors, regulatory peers, and same-class analogs so the team can compare candidates before a sourcing scramble.